Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center

References

• KelseySFJamesMHolubkovALResults of percutaneous transluminal coronary angioplasty in women. 1985–1986 National Heart, Lung, and Blood Institute’s Coronary Angioplasty RegistryCirculation1993877207278443892
   PubMed Web of Science ®Google Scholar
• MalenkaDJO’ConnorGTQuintonHDifferences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study GroupCirculation199694Suppl 9II99II1048901727
   PubMed Web of Science ®Google Scholar
• GlaserRSelzerFJacobsAKEffect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromesAm J Cardiol2006981446145017126647
   PubMed Web of Science ®Google Scholar
• NarinsCRLingFSFischiMIn-hospital mortality among women undergoing contemporary elective percutaneous coronary intervention: a reexamination of the gender gapClin Cardiol20062925425816796075
   PubMed Web of Science ®Google Scholar
• OnumaYKukrejaNDaemenJInterventional Cardiologists of ThoraxcenterImpact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) RegistriesJACC Cardiovasc Interv2009260361019628181
   PubMed Web of Science ®Google Scholar
• DuvernoyCSSmithDEManoharPGender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registryAm Heart J201015967768320362729
   PubMed Web of Science ®Google Scholar
• TillmannsHWaasWVossRGender differences in the outcome of cardiac interventionsHerz20053037538916132240
   PubMed Web of Science ®Google Scholar
• Ben-AmiTGilutzHPorathANo gender difference in the clinical management and outcome of unstable anginaIsr Med Assoc J2005722823215847201
   PubMed Web of Science ®Google Scholar
• SheibanILa SpinaCCavalleroESex-related differences in patients undergoing percutaneous unprotected left main stentingEuroIntervention2010579580020142193
   PubMed Web of Science ®Google Scholar
• SolinasENikolskyELanskyAJGender-specific outcomes after sirolimus-eluting stent implantationJ Am Coll Cardiol2007502111211618036446
   PubMed Web of Science ®Google Scholar
• PresbiteroPBelliGZavalloniD“Gender paradox” in outcome after percutaneous coronary intervention with paclitaxel eluting stentsEuroIntervention2008434535019110808
   PubMedGoogle Scholar
• ThompsonCAKaplanAVFriedmanBJGender-based differences of percutaneous coronary intervention in the drug-eluting stent eraCatheter Cardiovasc Interv200667253116345036
   PubMed Web of Science ®Google Scholar
• SuessenbacherADoerlerJAlberHGender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registryEuroIntervention2008427127619110794
   PubMedGoogle Scholar
• LanskyAJCostaRAMooneyMTAXUS-IV InvestigatorsGender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery diseaseJ Am Coll Cardiol2005451180118515837246
   PubMed Web of Science ®Google Scholar
• KovacicJCMehranRKarajgikarRFemale gender and mortality after percutaneous coronary intervention: results from a large registryCatheter Cardiovasc Interv20128051452122045678
   PubMed Web of Science ®Google Scholar
• BujaPD’AmicoGFacchinMGender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experienceInt J Cardiol2013168113914323103143
   PubMed Web of Science ®Google Scholar
• OgitaMMiyauchiKDohiTGender-based outcomes among patients with diabetes mellitus after percutaneous coronary intervention in the drug-eluting stent eraInt Heart J20115234835222188707
   PubMed Web of Science ®Google Scholar
• TuomainenPOYlitaloANiemeläMGender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trialJ Invasive Cardiol20122410410822388300
   PubMed Web of Science ®Google Scholar
• NiccoliGSguegliaGACosentinoNImpact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart diseaseEur J Prev Cardiol20121991492621840968
   PubMed Web of Science ®Google Scholar
• ShammasNWShammasGASharisPJerinMAge differences in long-term outcomes of coronary patients treated with drug eluting stents at a tertiary medical centerJ Aging Res2013201347102623819051
   PubMedGoogle Scholar
• US Food and Drug AdministrationCirculatory System Devices Panel. Notice of Meeting Available from: http://www.fda.gov/ohrms/dockets/ac/cdrh06.html#circulatoryAccessed June 26, 2014
   Google Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med20103621663167420445180
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation Everolimus-eluting and Paclitaxel-eluting Stents in Real-life Practice (COMPARE): a randomized trialLancet2010375971020120920060578
   PubMed Web of Science ®Google Scholar
• WaksmanRGhaliMGoodroeRPercutaneous Coronary Intervention with Second-generation Paclitaxel-eluting Stents Versus Everolimus-eluting Stents in United States Contemporary Practice (REWARDS TLX trial)Am J Cardiol201211081119112422762711
   PubMed Web of Science ®Google Scholar
• MahmoudiMDelhayeCWakabayashiKOutcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stentsAm J Cardiol20111071757176221497782
   PubMed Web of Science ®Google Scholar
• BrodieBRStuckeyTDowneyWSTENT (Strategic Transcatheter Evaluation of New Therapies) GroupOutcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) GroupJACC Cardiovasc Interv2008140541419463338
   PubMed Web of Science ®Google Scholar
• FlinkLESciaccaRRBierMLWomen at risk for cardiovascular disease lack knowledge of heart attack symptomsClin Cardiol20133613313823338973
   PubMed Web of Science ®Google Scholar